Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Open Access
- 6 August 2007
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (8), 1178-1182
- https://doi.org/10.1111/j.1440-1746.2007.04997.x
Abstract
Hypoxia enhances proliferation, angiogenesis, metastasis, chemoresistance, and radioresistance of hepatocellular carcinoma (HCC); suppresses differentiation and apoptosis of HCC; and consequently leads to resistance of transarterial embolization (with or without chemotherapy). Because transarterial embolization contributes to angiogenesis via inducing hypoxia, therapy combined with transarterial embolization and antiangiogenic therapy provides a new strategy for the treatment of HCC. Unfortunately, hypoxia leads to the escape of HCC cells from transarterial embolization and antiangiogenic therapy. Thus combined therapy that induces and targets hypoxia may be of benefit to HCC patients. Because angiogenesis plays an important role in recurrence of HCC after resection, antiangiogenic therapy is beneficial to HCC patients following surgical resection of the tumor.This publication has 43 references indexed in Scilit:
- Suppression of hypoxia inducible factor-1α (HIF-1α) by YC-1 is dependent on murine double minute 2 (Mdm2)Biochemical and Biophysical Research Communications, 2006
- Hypoxia protects HepG2 cells against etoposide-induced apoptosis VIA a HIF-1-independent pathwayExperimental Cell Research, 2006
- Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cellsMolecular Cancer Therapeutics, 2006
- Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel‐Lindau suppression and HIF1α activationInternational Journal of Cancer, 2006
- Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expressionJournal of Hepatology, 2005
- Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell linesCarcinogenesis: Integrative Cancer Research, 2004
- Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectivesZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiencyOncogene, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolizationHistopathology, 2001